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Lagging chromosomes as markers of CIN. (A) Schematic diagram of a mitotic spindle at metaphase and at anaphase, depicting normally 
attached “bi-oriented” chromosomes as well as 1 lagging chromosome, which is improperly attached simultaneously to both spindle poles. Upon 
anaphase onset, this improper attachment can lead to lagging chromosomes. Microtubules, kinetochores, and chromatin are depicted in green, 
red, and blue, respectively. (B) H&E-stained cells undergoing anaphase from tumor biopsies of patients with DLBCL, exhibiting lagging chromo-
somes (arrow, middle) as well as chromatin bridges (arrow, right), which frequently result from lagging chromosomes. Scale bar: 5 μm.
science in medicine
































































































The relationship between ploidy and CIN in the context of tumor initia-
tion and growth. Frequent chromosome missegregation events lead to 
aneuploidy, which in turn leads to transcriptome imbalance and addi-
tional chromosome missegregation as well as DNA damage. Aneu-
ploidy brought about by chromosome missegregation also triggers the 
p53/p21 tumor suppressor pathway, which in turn limits further pro-
liferation of aneuploid cells. The circular arrow depicts the proposed 
self-propagating nature of CIN in tumor cells.
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